175 related articles for article (PubMed ID: 20923841)
1. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial.
Dormandy E; Gulliford M; Bryan S; Roberts TE; Calnan M; Atkin K; Karnon J; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Tsianakas V; Jones P; Marteau TM
BMJ; 2010 Oct; 341():c5132. PubMed ID: 20923841
[TBL] [Abstract][Full Text] [Related]
2. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial.
Dormandy E; Bryan S; Gulliford MC; Roberts TE; Ades AE; Calnan M; Atkin K; Karnon J; Barton PM; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Davis V; Brown K; Juarez-Garcia A; Tsianakas V; Marteau TM
Health Technol Assess; 2010 Apr; 14(20):1-160. PubMed ID: 20416236
[TBL] [Abstract][Full Text] [Related]
3. Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study.
Dormandy E; Gulliford MC; Reid EP; Brown K; Marteau TM;
Br J Gen Pract; 2008 Mar; 58(548):154-9. PubMed ID: 18318968
[TBL] [Abstract][Full Text] [Related]
4. Screening for sickle cell and thalassaemia in primary care: a cost-effectiveness study.
Bryan S; Dormandy E; Roberts T; Ades A; Barton P; Juarez-Garcia A; Andronis L; Karnon J; Marteau TM
Br J Gen Pract; 2011 Oct; 61(591):e620-7. PubMed ID: 22152833
[TBL] [Abstract][Full Text] [Related]
5. Offering antenatal sickle cell and thalassaemia screening in primary care: a pre-post evaluation of a brief type of communication skills training.
Dormandy E; Reid E; Tsianakas V; O'Neil B; Gill E; Marteau TM
Patient Educ Couns; 2012 Oct; 89(1):129-33. PubMed ID: 22742984
[TBL] [Abstract][Full Text] [Related]
6. Impact on informed choice of offering antenatal sickle cell and thalassaemia screening in primary care: a randomized trial.
Brown K; Dormandy E; Reid E; Gulliford M; Marteau T
J Med Screen; 2011; 18(2):65-75. PubMed ID: 21852698
[TBL] [Abstract][Full Text] [Related]
7. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
[TBL] [Abstract][Full Text] [Related]
8. Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of GPs' experiences.
Tsianakas V; Calnan M; Atkin K; Dormandy E; Marteau TM
Br J Gen Pract; 2010 Nov; 60(580):822-8. PubMed ID: 21062549
[TBL] [Abstract][Full Text] [Related]
9. Antenatal screening for haemoglobinopathies in primary care: a whole system participatory action research project.
Thomas P; Oni L; Alli M; St Hilaire J; Smith A; Leavey C; Banarsee R
Br J Gen Pract; 2005 Jun; 55(515):424-8. PubMed ID: 15970065
[TBL] [Abstract][Full Text] [Related]
10. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
[TBL] [Abstract][Full Text] [Related]
11. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010849. PubMed ID: 29537064
[TBL] [Abstract][Full Text] [Related]
12. Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of women's experiences and expectations of participation.
Tsianakas V; Atkin K; Calnan MW; Dormandy E; Marteau TM
Health Expect; 2012 Jun; 15(2):115-25. PubMed ID: 21366810
[TBL] [Abstract][Full Text] [Related]
13. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
[TBL] [Abstract][Full Text] [Related]
14. First-trimester pregnancy scanning as a screening tool for high-risk and abnormal pregnancies in a district general hospital setting.
Drysdale K; Ridley D; Walker K; Higgins B; Dean T
J Obstet Gynaecol; 2002 Mar; 22(2):159-65. PubMed ID: 12521697
[TBL] [Abstract][Full Text] [Related]
15. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
[TBL] [Abstract][Full Text] [Related]
16. Regimens of ultrasound surveillance for twin pregnancies for improving outcomes.
Woolcock JG; Grivell RM; Dodd JM
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011371. PubMed ID: 29108135
[TBL] [Abstract][Full Text] [Related]
17. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
18. Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.
Anionwu EN; Patel N; Kanji G; Renges H; Brozović M
J Med Genet; 1988 Nov; 25(11):769-72. PubMed ID: 3236357
[TBL] [Abstract][Full Text] [Related]
19. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry.
Modell B; Harris R; Lane B; Khan M; Darlison M; Petrou M; Old J; Layton M; Varnavides L
BMJ; 2000 Feb; 320(7231):337-41. PubMed ID: 10657326
[TBL] [Abstract][Full Text] [Related]
20. Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis.
Hill M; Compton C; Karunaratna M; Lewis C; Chitty L
J Genet Couns; 2014 Dec; 23(6):1012-21. PubMed ID: 24788196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
